Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_assertion type Assertion NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_head.
- NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_assertion description "[EGFR overexpression (2+ or 3+) was found in 87.5% (35/40) of the laryngeal primary tumors and 82.5% (33/40) of the corresponding lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_provenance.
- NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_assertion evidence source_evidence_literature NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_provenance.
- NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_assertion SIO_000772 18172732 NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_provenance.
- NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_assertion wasDerivedFrom befree-2016 NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_provenance.
- NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_assertion wasGeneratedBy ECO_0000203 NP648157.RAqbi3cYHhk-_A_bKxJPt89DHaFtdIq1qQgNK4F41l2qw130_provenance.